| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/05/2004 | CA2493590A1 Auto-stimulating cells and method for making and using the same |
| 02/05/2004 | CA2493158A1 Preparation of 1h-imidazo [4,5-c] quinolin-4-amines via novel 1h-imidazo [4,5-c] quinolin-4-cyano and 1h-imidazo [4,5-c] quinolin-4-carboxamide intermediates |
| 02/05/2004 | CA2493156A1 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 02/05/2004 | CA2493074A1 Use of a rhein in a therapeutic treatment requiring a rise in the rate of heme oxygenase |
| 02/05/2004 | CA2492447A1 Taci antibodies and uses thereof |
| 02/05/2004 | CA2492333A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 02/05/2004 | CA2489165A1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 02/04/2004 | EP1386933A1 Cytokine antagonists and agonists |
| 02/04/2004 | EP1386932A1 Improved humanized immunoglobulins |
| 02/04/2004 | EP1386923A1 Novel adenine derivatives |
| 02/04/2004 | EP1386166A2 Anti-epileptogenic agents |
| 02/04/2004 | EP1386155A2 Therapeutic and diagnostic uses of antibody specificity profiles |
| 02/04/2004 | EP1385980A2 Yeast strains autonomously producing steroids |
| 02/04/2004 | EP1385977A2 Secreted proteins |
| 02/04/2004 | EP1385966A2 Recombinant fusion proteins and the trimers thereof |
| 02/04/2004 | EP1385954A2 Proteins associated with cell growth, differentiation, and death |
| 02/04/2004 | EP1385952A2 Methods of inhibiting expression of a target gene in mammalian cells |
| 02/04/2004 | EP1385937A1 Delivery of polynucleotide agents to the central nervous sysstem |
| 02/04/2004 | EP1385934A2 Pufa polyketide synthase systems and uses thereof |
| 02/04/2004 | EP1385886A1 Method for preparing human immunoglobulin concentrates for therapeutic use |
| 02/04/2004 | EP1385883A2 Transmembrane proteins |
| 02/04/2004 | EP1385882A2 Peptides and related molecules that bind to tall-1 |
| 02/04/2004 | EP1385878A2 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 02/04/2004 | EP1385864A1 Vascular endothelial growth factor 2 |
| 02/04/2004 | EP1385848A2 Phtalazinones derivatives useful as pde4/7 inhibitors |
| 02/04/2004 | EP1385845A1 N-aroyl cyclic amines |
| 02/04/2004 | EP1385843A1 Arylindenopyridines with pde inhibiting activity |
| 02/04/2004 | EP1385839A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/04/2004 | EP1385836A2 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/04/2004 | EP1385835A1 Benzoxazinone derivatives for use in the treatment of angiogenesis |
| 02/04/2004 | EP1385825A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 02/04/2004 | EP1385554A2 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins |
| 02/04/2004 | EP1385550A2 Therapeutic method for inducing tolerance |
| 02/04/2004 | EP1385541A1 Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and qs-21 |
| 02/04/2004 | EP1385538A2 Chimeric vaccines |
| 02/04/2004 | EP1385533A1 Module of pd-1 interactions with its ligands |
| 02/04/2004 | EP1385524A1 Pyrazolopyrimidines as therapeutic agents |
| 02/04/2004 | EP1385519A2 Compounds for treating inflammatory diseases |
| 02/04/2004 | EP1385508A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/04/2004 | EP1385502A2 Method for the production of anhydrous, pharmaceutical formulations of xanthogenates |
| 02/04/2004 | EP1385500A1 Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 02/04/2004 | EP1385493A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties |
| 02/04/2004 | EP1385452A1 Ophthalmic drug delivery device |
| 02/04/2004 | EP1228147B1 Dye labeled imidazoquinoline compounds |
| 02/04/2004 | EP1115697B1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 02/04/2004 | EP1021196B1 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 02/04/2004 | CN1473161A Pyrazole compounds as protein kinase inhibitors |
| 02/04/2004 | CN1473148A Novel crystals of N-hydroxy-2(S)-methyl-5-ethoxymethoxy-4(S)-[N-(4- phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing crystals as active ingredient |
| 02/04/2004 | CN1473052A PSGL-1 regulator |
| 02/04/2004 | CN1473051A Use of immidazoquinolinamines as adjuvants in DNA vaccination |
| 02/04/2004 | CN1473048A 1 alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 02/04/2004 | CN1473043A Method for treating allergies using substituted pyrazoles |
| 02/04/2004 | CN1472319A Method of expressing thymys peptide alpha by yeast and use thereof |
| 02/04/2004 | CN1472218A Medicine compound for preventing diabets mellitus and preparing method thereof |
| 02/04/2004 | CN1471975A Immune adjusting agent |
| 02/04/2004 | CN1471974A Anti-inflammatory agent |
| 02/04/2004 | CN1471970A Recombination low-dosage human alpha-2b(IFN-alpha-2b) interferon lozenge and preparing method thereof |
| 02/04/2004 | CN1471945A Threewingnut drop for immune disease |
| 02/04/2004 | CN1471935A Soybean extractnig liquid for increasing natural killer cell activity |
| 02/04/2004 | CN1471926A Injection for enhancing immunity and its preparing method |
| 02/04/2004 | CN1137123C Azolo triazizes and pyrimidines |
| 02/04/2004 | CN1137097C Aminoalkyl-3,4-dihydroquindine derivates as No-synthase inhibitors |
| 02/04/2004 | CN1137086C 2-aminopropane-1,3-diol compounds, medical use therof and intermediates in synthesizing the same |
| 02/04/2004 | CN1136848C Application of bilirubin bitaurine sodium and its bilirubin derivative in preparing anti-HTV medicine |
| 02/04/2004 | CN1136845C 9-cis-visual yellow acid and use of its medicinal salt |
| 02/04/2004 | CN1136838C Solid, quick dissolving cetirizine fomulation |
| 02/03/2004 | US6686467 Inhibitors of the production of cytokines such as tumour necrosis factor (hereinafter tnf), for example tnf alpha , and various members of the interleukin (hereinafter il) family, for example il-1, il-6 and il-8 |
| 02/03/2004 | US6686386 Combating photoinduced or chronological ageing of skin with retenoic acid receptor agonist |
| 02/03/2004 | US6686382 N-(isoxazolyl)thienylsulfonamides, n-(isoxazolyl)furylsulfonamides, n-(isoxazolyl)pyrrolylsulfonamides and n-(isoxazolyl)phenylsulfonamides; inhibit endothelin |
| 02/03/2004 | US6686373 Analgesics; antiinflammatory agent |
| 02/03/2004 | US6686347 Phthalazine derivatives for treating inflammatory diseases |
| 02/03/2004 | US6686346 Formulation |
| 02/03/2004 | US6686343 Triazolopurine derivatives, pharmaceutical compositions containing the derivatives, and adenosine A3 receptor affinitive agents |
| 02/03/2004 | US6686341 Nutritional compositions which contain slightly negatively charged, non-digestible polysaccharides and use thereof for reducing transport through tight junctions |
| 02/03/2004 | US6685950 Methods of treating viral infections |
| 02/03/2004 | US6685947 Derived from canine distemper virus |
| 02/03/2004 | US6685936 Administering lymphocytes |
| 02/03/2004 | US6685924 Conjugate, its preparation and use |
| 02/03/2004 | US6685911 Sensitization process for antigen-presenting cells and means for implementing the process |
| 02/03/2004 | CA2245661C Multiple sclerosis treatment |
| 02/03/2004 | CA2100655C Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 01/31/2004 | CA2436469A1 Composition for heart disease, method to prepare same and uses thereof |
| 01/29/2004 | WO2004009816A1 Methods of treating conditions associated with an edg-1 receptor |
| 01/29/2004 | WO2004009800A1 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/29/2004 | WO2004009784A2 Novel inhibitors of kinases |
| 01/29/2004 | WO2004009613A1 Anti-inflammatory or anti-allergic androstane complexes |
| 01/29/2004 | WO2004009602A1 Pyrazolopyrimidines as kinase inhibitors |
| 01/29/2004 | WO2004009601A1 Azaindole kinase inhibitors |
| 01/29/2004 | WO2004009596A2 Pyrazolopyrimidines as kinase inhibitors |
| 01/29/2004 | WO2004009592A1 Bicyclic unsaturated tertiary amine compound |
| 01/29/2004 | WO2004009588A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 01/29/2004 | WO2004009582A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 01/29/2004 | WO2004009579A1 Novel compounds |
| 01/29/2004 | WO2004009563A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 01/29/2004 | WO2004009560A1 Novel bio-active molecules |
| 01/29/2004 | WO2004009557A1 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 01/29/2004 | WO2004009556A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 01/29/2004 | WO2004009550A1 Piperidine derivatives and their use as selective inhibitors of mip-1alpha binding to its receptor ccr1 |
| 01/29/2004 | WO2004009547A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 01/29/2004 | WO2004009546A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |